BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 23, 2003
View Archived Issues
Spotlight on endometriosis
Read More
AlphaVax receives new award from NIAID
Read More
Celera Diagnostics enters research collaboration with Merck & Co.
Read More
Discovery Partners and Inspire expand collaboration
Read More
Lexicon reviews gene knockouts to predict efficacy of new drugs
Read More
MethylGene and Taiho enter HDAC inhibitor collaboration
Read More
New antiherpesvirus agents prepared and tested at GSK
Read More
Curacyte claims novel urokinase inhibitors with utility in cancer therapy
Read More
Roche describes new AKT inhibitors as potential propapoptotic antitumor agents
Read More
Dual NO donors/antioxidants and their use in syndrome X and other disorders
Read More
New sGC activators for erectile dysfunction claimed by Abbott researchers
Read More
Merck Frosst and AxyS patent describes new cathepsin K inhibitors
Read More
Novel protein kinase inhibitors identified by Vertex scientists
Read More
Topical microbicides safe in healthy and HIV-infected men
Read More
Ferumoxtran-10 improves detection of nodal metastases by MRI
Read More
Topiramate improves body composition and blood pressure of obese patients
Read More
Acorda awarded grants to support research in extracellular matrix modification
Read More
Once-weekly Enbrel approved
Read More
Phase II OSCAR trial evaluates AGIX-4207 for rheumatoid arthritis
Read More
Approvable letter issued for expansion of Provigil labeling
Read More
Dose-related performance improvement with CX-516 after sleep deprivation
Read More
Phase III program evaluates milnacipran for FMS
Read More
Positive preliminary results announced for tolevamer in C. difficile diarrhea
Read More
Keryx initiates phase II/III program of KRX-101 for diabetic nephropathy
Read More
Encouraging preliminary phase II results for ThGRF in COPD wasting
Read More
Vion licenses Triapine rights in China, Taiwan, Hong Kong and Macao
Read More
Novel antiplatelet/antithrombotic agent acting through the L-arginine/NO pathway
Read More